John P Phd Longenecker insider trades: Pacira BioSciences (PCRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 3, 2022 | PCRX | ↓ Sell | 7,000 | $71.73 | $502K | Direct | Mar 7, 2022 (4d) |
| Mar 1, 2021 | PCRX | ↓ Sell | 5,000 | $72.26 | $361K | Direct | Mar 3, 2021 (2d) |
| Dec 2, 2019 | PCRX | ↓ Sell | 1,300 | $46.13 | $60K | Direct | Dec 4, 2019 (2d) |
| Aug 10, 2018 | ALRN | ↑ Buy | 10,000 | $2.45 | $25K | Direct | Aug 14, 2018 (4d) |
| Jan 12, 2016 | PCRX | ↑ Buy | 300 | $66.55 | $20K | Direct | Jan 14, 2016 (2d) |
| Mar 12, 2015 | PCRX | ↓ Sell | 3,000 | $95.28 | $286K | Direct | Mar 16, 2015 (4d) |
| Dec 29, 2014 | PCRX | ↓ Sell | 1,000 | $93.32 | $93K | Direct | Dec 30, 2014 (1d) |
| Sep 29, 2014 | PCRX | ↓ Sell | 1,000 | $96.40 | $96K | Direct | Sep 30, 2014 (1d) |
| Jun 30, 2014 | PCRX | ↓ Sell | 1,000 | $91.60 | $92K | Direct | Jul 2, 2014 (2d) |
| Mar 28, 2014 | PCRX | ↓ Sell | 1,000 | $64.63 | $65K | Direct | Mar 31, 2014 (3d) |
| Dec 30, 2013 | PCRX | ↓ Sell | 2,500 | $55.55 | $139K | Direct | Jan 2, 2014 (3d) |
| Sep 30, 2013 | PCRX | ↓ Sell | 2,500 | $46.74 | $117K | Direct | Oct 2, 2013 (2d) |
| Jun 28, 2013 | PCRX | ↓ Sell | 2,000 | $28.09 | $56K | Direct | Jul 2, 2013 (4d) |
| Mar 28, 2013 | PCRX | ↓ Sell | 2,000 | $28.49 | $57K | Direct | Apr 1, 2013 (4d) |
| Dec 12, 2008 | FVRL | ↓ Sell | 172,060 | $0.02 | $4K | Direct | Dec 15, 2008 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PCRX insiders
Open-market trades in the last 12 months
About John P Phd Longenecker's insider trades
John P Phd Longenecker is a director at Pacira BioSciences (PCRX). Since Dec 12, 2008, John has reported 2 open-market purchases worth $44K and 13 sales worth $1.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), option exercises (13 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.